A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS).

Prasad Nishtala, Teyuan Chyou

Research output: Contribution to journalLetter

3 Downloads (Pure)
Original languageEnglish
Pages (from-to)607-609
Number of pages3
JournalDrug Safety
Volume43
Issue number6
DOIs
Publication statusPublished - 4 Apr 2020

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this